Summary
- Current Price
- As of today, GYRE price is $4.56, down -28.94% on
- Current Price All-Time High
- GYRE price is currently -99.99% below its historical high of $47,990.25 set on
- Market Cap
- GYRE current market cap is $483M, down -30.54% year-over-year
- Revenue
- GYRE current annual revenue is $116.59M, up +10.24% year-over-year
- Next Earnings
- The next earnings release for GYRE is on
Profile
| Metric | Value |
|---|---|
| Full Name | Gyre Therapeutics, Inc. |
| Ticker | NASDAQ: GYRE |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | gyretx.com |
| Employees | 579 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $4.56 | |
| Price, 1D Change | -28.94% | |
| $483M | ||
| - | ||
| - | ||
| 1.74 | ||
| $116.59M | ||
| Revenue, 1Y Change | +10.24% | |
| $0.02 | ||
| EPS, 1Y Change | -53.22% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $7.20 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:15 | |
| Next Split | N/A | N/A |
| Last Ticker Change | CBIO | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| $0.02 | ||
| EPS Estimate | -$0.40 | N/A |
| EPS Est. Change | -1,877.78% | N/A |
| $116.59M | ||
| Revenue Estimate | $109.50M | N/A |
| Revenue Est. Change | -6.08% | N/A |
| Current Price | $4.56 | |
| Price Target | $18.00 | - |
| Price Tgt. Change | +295.17% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.05 | - | |
| $0.13 | $0.02 | -82.69% | |
| -$0.40 | N/A | -1,877.78% | |
| -$0.24 | N/A | -1,144.44% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $101.39M | $105.76M | +4.31% | |
| $114.83M | $116.59M | +1.53% | |
| $109.50M | N/A | -6.08% | |
| $139.60M | N/A | +19.74% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $4.56 | |
| $6.99 | ||
| $6.73 | ||
| $6.98 | ||
| $6.57 | ||
| -$0.29 | ||
| 1.74 | ||
| $0.48 | ||
| 29.49 | ||
| 171.14% |
Dividends
| Metric | Value | Date |
|---|---|---|
| Last Paid | $7.20 | |
| Upcoming | N/A | N/A |
| - | ||
| Total Dividend | - | |
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $116.59M | ||
| $0.02 | ||
| $111.17M | ||
| 95.35% | ||
| $11.49M | ||
| 9.86% | ||
| $9.88M | ||
| 8.47% | ||
| $14.01M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.01 | ||
| 5.60 | ||
| 5.04 | ||
| - | ||
| 1 | ||
| 13.56 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 4.05 | ||
| 4.48 | ||
| -40.68 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $106.03M | ||
| $52.43M | ||
| $166.13M | ||
| $102.37M | ||
| $23.00M | ||
| $18.29M | ||
| $939.00K | ||
| $636.00K | ||
| $124.00K |
Expenses
| Metric | Value | Date |
|---|---|---|
| $111.56M | ||
| $99.68M | ||
| $5.42M | ||
| $0.00 | ||
| $2.52M | ||
| $0.00 | ||
| $4.56M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$477.00K | ||
| -$474.00K | ||
| $25.87M | ||
| $1.92M | ||
| -$2.40M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Jefferies | ||
| HC Wainwright & Co. |
Analyst sentiment
Institutional ownership
Screeners with GYRE
FAQ
- What is the ticker symbol for Gyre Therapeutics, Inc.?
- The ticker symbol for Gyre Therapeutics, Inc. is NASDAQ:GYRE
- Does Gyre Therapeutics, Inc. pay dividends?
- No, Gyre Therapeutics, Inc. does not pay dividends
- What sector is Gyre Therapeutics, Inc. in?
- Gyre Therapeutics, Inc. is in the Healthcare sector
- What industry is Gyre Therapeutics, Inc. in?
- Gyre Therapeutics, Inc. is in the Biotechnology industry
- What country is Gyre Therapeutics, Inc. based in?
- Gyre Therapeutics, Inc. is headquartered in United States
- When did Gyre Therapeutics, Inc. go public?
- Gyre Therapeutics, Inc. initial public offering (IPO) was on April 12, 2006
- Is Gyre Therapeutics, Inc. in the S&P 500?
- No, Gyre Therapeutics, Inc. is not included in the S&P 500 index
- Is Gyre Therapeutics, Inc. in the NASDAQ 100?
- No, Gyre Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Gyre Therapeutics, Inc. in the Dow Jones?
- No, Gyre Therapeutics, Inc. is not included in the Dow Jones index
- When was Gyre Therapeutics, Inc. last earnings report?
- Gyre Therapeutics, Inc.'s most recent earnings report was on August 7, 2026
- When does Gyre Therapeutics, Inc. report earnings?
- The next expected earnings date for Gyre Therapeutics, Inc. is November 5, 2026
Data Sources & References
- GYRE Official Website www.gyretx.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1124105/000119312526106251/0001193125-26-106251-index.htm
- GYRE Profile on Yahoo Finance finance.yahoo.com/quote/GYRE
- GYRE Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gyre